The global market for the Stringent government policies for preventing hospital-associated infections and rise in the number of surgeries to drive the infection surveillance solutions system is anticipated to develop at a compound annual growth rate (CAGR) of 14.4% throughout the course of the forecast, to reach $1724.22 million by 2030.

Emergence and high prevalence of acute diseases including urinary tract infection, typhoid, tuberculosis, influenza, and sepsis along with the need for effective infection control procedures within healthcare units are the key drivers for the global market growth for infection surveillance solutions. Besides, stringent government regulations and policies to restrict and avoid infections in healthcare units further show a positive impact on the global infection surveillance solutions system market. Hence, various healthcare centers including clinics, hospitals, outpatient care settings are implementing infection surveillance solutions in terms of safety which will promote the growth of the market worldwide. Additionally, other drivers such as increasing attention toward reducing healthcare-acquired infections (HAI), the availability of latest surveillance technologies including data mining surveillance coupled with HAI surveillance workflow, and the rising number of various invasive procedures further contribute to the growth of the global infection surveillance solutions system market. However, issues related to software integration, lack of sanitation, less expenditure for the adoption of infection surveillance solutions along with lack of awareness related to hygiene in developing countries are likely to hinder the growth of the global infection surveillance solutions market over the forecast period.

Growing technological advancement in IT system along with the rising capacity of IT system to perform analytic processing drive the growth of the global market

IT systems help in emerging analytical and infection surveillance solutions for application in the healthcare industry along with automated HAI surveillance are further shows a positive impact on the market across the globe. Based on types of offered solutions, the global infection surveillance solutions market is classified into software and services. The software segment is likely to dominate the global market as compared to service owing to high demand and perpetual evolution og software in terms patient data, analysis and interpretation.

North America is likely to hold the highest revenue share in the global market

Geographically global infection surveillance solutions market is classified into North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa. Among these regions, North America is likely to hold the largest market share owing to the large concentration of medical technology research industries. Other factors such as increasing R&D in medical science and a growing number of HAI patients are propelling the growth of the market in North America. According to an article published in the Centers for Disease Control and Prevention (CDC), in American hospitals alone, approx 1.7 million infections and 99,000 associated deaths are estimated each year; where 32% of all HAIs are urinary tract infections and 22% are surgical site infections. Therefore, as a result, demand for infection surveillance solutions is rising to avoid the infectious disease across the region, which further propelling the significant growth in the North American market.

Key Market Players

• Becton, Dickinson and Company
• Premier Inc.
• Wolters Kluwer N.V.
• Baxter International Inc.
• Gojo Industries, Inc.
• RadicaLogic Technologies, Inc.
• Truven Health Analytics Inc
• DEB Group Ltd.
• Hygreen, Inc.

Key Segment Of The infection surveillance solutions system market

By Component, 2022-2030 (USD Million)            
    o    Software 
    o    Services 
        •    Implementation 
        •    Support & Maintenance
        •    Training & Consulting
By Deployment, 2022-2030 (USD Million)
    •    On-Premises 
    •    Web-Based
By End User, 2022-2030 (USD Million)
    •    Hospitals 
    •    Clinics 
    •    Ambulatory Service 
    •    Specialty Center 
    •    Others
Regional Overview, 2022-2030 (USD Million)
    North America
      •    US
      •    Canada
    Europe
      •    Germany
      •    France
      •    UK
      •    Rest of Europe
    Asia Pacific
      •    China
      •    India
      •    Japan
      •    Rest of Asia Pacific
    South America
      •    Mexico
      •    Brazil
      •    Rest of South America
    Middle East and South Africa